InsidersTradesSigma
Total declarations
Company
▲ Purchases (6 ops.)
▼ Sales (0 ops.)
Explore the complete record of transactions filed by De Rubertis Francesco, Director. Officer active across 1 companies, notably Centessa Pharmaceuticals plc. In total, 9 disclosures have been recorded. Total volume traded: €1.7m. The latest transaction was disclosed on 21 March 2022 — J. Regulator: SEC (Form 4). All data is free.
Declarations9 total
01,794,211 shares0
Ordinary Shares
SEC:0000899243-22-011941:0·
€379,74633,530 shares@ €11.32560.0062% mcap43.8% of flow
Ordinary Shares
SEC:0000899243-21-046972·
Ideal exit: 29 Aug 2022 (T+270)
€379,74633,530 shares@ €11.32560.0062% mcap21.9% of flow
Ordinary Shares
SEC:0000899243-21-046972:0·
Ideal exit: 29 Aug 2022 (T+270)
€370,32735,992 shares@ €10.28920.0060% mcap42.7% of flow
Ordinary Shares
SEC:0000899243-21-046599·
Ideal exit: 27 Aug 2022 (T+270)
€370,32735,992 shares@ €10.28920.0060% mcap21.4% of flow
Ordinary Shares
SEC:0000899243-21-046599:0·
Ideal exit: 27 Aug 2022 (T+270)
€116,72411,543 shares@ €10.11210.0019% mcap13.5% of flow
Ordinary Shares
SEC:0000899243-21-046320·
Ideal exit: 23 Aug 2022 (T+270)
€116,72411,543 shares@ €10.11210.0019% mcap6.7% of flow
Ordinary Shares
SEC:0000899243-21-046320:0·
Ideal exit: 23 Aug 2022 (T+270)
1,886,990 shares
Ordinary Shares
SEC:0000899243-21-022071·
1,886,990 shares
Ordinary Shares
SEC:0000899243-21-022071:0·
9 of 9 declarations
About De Rubertis Francesco
Francesco De Rubertis is a Board Member at Centessa Pharmaceuticals plc. He plays a key role in the governance of the company, contributing to strategic decision-making and overseeing activities.
